Back
Endava Plc Vs. Rhythm Pharmaceuticals, Inc. Industry Stock Comparison
Sell
29
DAVA
Endava Plc
Last Price:
$6.57
Seasonality Move:
-3.62%
Buy
61
RYTM
Rhythm Pharmaceuticals, Inc.
Last Price:
$117.57
Seasonality Move:
-9.01%
Sell
29
Endava Plc (DAVA)
is a Sell
Is Endava Plc a Buy, Sell or Hold?
-
The current Endava Plc [DAVA] share price is $6.59. The Score for DAVA is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
DAVA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Rhythm Pharmaceuticals, Inc. (RYTM)
is a Buy
Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $104.77. The Score for RYTM is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
RYTM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DAVA Stock Price Chart
What is Endava Plc's stock price today?
-
The Endava Plc share price today is $6.59Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DAVA is experiencing selling pressure, which indicates risk of future bearish movement.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals, Inc.'s stock price today?
-
The Rhythm Pharmaceuticals, Inc. share price today is $104.77Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight buying pressure.
DAVA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.39 | Sell |
| Relative Strength Index (14 RSI): | 42.23 | Sell |
| Chaikin Money Flow: | -510615 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.1 | Buy |
| Relative Strength Index (14 RSI): | 51.18 | Buy |
| Chaikin Money Flow: | 492572 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
DAVA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.5 | Buy |
| 20-day SMA: | 6.41 | Buy |
| 50-day SMA: | 7.87 | Sell |
| 200-day SMA: | 13.75 | Sell |
| 8-day EMA: | 6.56 | Buy |
| 20-day EMA: | 6.77 | Sell |
| 50-day EMA: | 7.53 | Sell |
| 200-day EMA: | 5.58 | Buy |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 104 | Buy |
| 20-day SMA: | 103.19 | Buy |
| 50-day SMA: | 104.46 | Buy |
| 200-day SMA: | 81.11 | Buy |
| 8-day EMA: | 104.12 | Buy |
| 20-day EMA: | 104.09 | Buy |
| 50-day EMA: | 102.96 | Buy |
| 200-day EMA: | 86.07 | Buy |
Endava Plc Earnings Growth & DAVA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and a decrease next year of $0.47 per share.
Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and an increase next year of $0.56 per share.
Endava Plc Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals, Inc. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||